Insights Into Metastatic Colorectal Cancer Management

This report presents insights into the management of metastatic colorectal cancer (mCRC) as discussed in a session led by experts from Mayo Clinic and moderated by Ironwood Cancer & Research Centers. The objectives included assessing differences in treatment practices between academic and community settings, understanding clinical factors influencing therapy decisions, and evaluating physician awareness of emerging therapies. The findings indicate a shift towards biomarker-driven management of mCRC, with community oncologists reporting access to diagnostics and adherence to NCCN Guidelines. The report highlights the collaborative relationship between academic and community physicians, emphasizing shared decision-making and referral practices. It also addresses barriers to adopting newer therapies, particularly financial toxicity associated with oral agents. The report includes demographic data on attending physicians and outlines the session's agenda, which covered various aspects of mCRC management, including shared decision-making, treatment practices, and the integration of new therapies.